{
    "2019-10-21": [
        [
            {
                "time": "",
                "original_text": "复旦张江积极落实审核意见 等待重新上会审议",
                "features": {
                    "keywords": [
                        "复旦张江",
                        "落实审核意见",
                        "重新上会",
                        "审议"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "艾迪药业第一大客户销售占比超六成 三年半投1.6亿研发占营收19%",
                "features": {
                    "keywords": [
                        "艾迪药业",
                        "客户销售占比",
                        "研发投入",
                        "营收占比"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}